The Largest Antibiogram Study, in its Phase 2, is a collaborative effort led by Jawaharlal Institute of Postgraduate Medical Education and Research (JIPMER), with Ibhar serving as a technology partner. This phase represents a crucial continuation of the study’s initial success, with a focus on combating antimicrobial resistance (AMR).

Partnered with the World Health Organization (WHO) as a technical ally, this phase builds upon the extensive data and insights gathered in Phase 1. The study’s holistic approach involves not only understanding resistance patterns but also implementing evidence-based strategies for effective antibiotic stewardship and surveillance.